Related Experiment Video
Updated: Jul 1, 2026

Quantification of Monocyte Transmigration and Foam Cell Formation from Individuals with Chronic Inflammatory Conditions
Published on: October 17, 2017
Lipa regulates myeloid differentiation and is essential for intra-plaque macrophage accumulation during atherogenesis
Tianhan Li1, Juanjuan Qiu2, Haoyue Zhang2
1School of Basic Medical Medicine, Henan Medical University, Xinxiang, China; Laboratory of Genetic Regulators in the Immune System, School of Medical Technology, Henan Medical University, Xinxiang, China.
Insights
Lysosomal acid lipase (LIPA) deficiency in macrophages significantly reduces atherosclerosis by decreasing foam cell formation and macrophage accumulation. This suggests LIPA is a potential therapeutic target for treating atherosclerosis.
Area of Science:
- Cardiovascular Biology
- Lipid Metabolism
- Immunology
Background:
- Lysosomal acid lipase (LIPA) is linked to coronary artery disease and highly expressed in macrophages, yet its role there is unclear.
- Elevated LIPA in monocytes/macrophages and reduced levels in liver/plasma of at-risk individuals suggest a macrophage-specific role in atherosclerosis.
- Investigating macrophage LIPA's influence on atherosclerosis is crucial, given challenges in studying LIPA-deficient models.
Purpose of the Study:
- To determine the functional importance of macrophage Lysosomal acid lipase (LIPA) in the development of atherosclerosis.
- To investigate the impact of LIPA deficiency and heterozygosity in macrophages on atherosclerosis progression in vivo.
- To elucidate the molecular mechanisms underlying LIPA's role in macrophage lipid handling and foam cell formation.
Main Methods:
- Generated LIPA-deficient (Lipa-/-) and heterozygous (Lipa+/-) mice on an Apoe-/- background to model atherosclerosis.
- Utilized bone marrow transplantation to assess the role of macrophage-specific LIPA expression.
- Employed flow cytometry, single-cell RNA sequencing, and in vitro macrophage assays to analyze lipid uptake, CD36 expression, and foam cell formation.
Main Results:
- LIPA deficiency (Lipa-/-Apoe-/-) and heterozygosity (Lipa+/-Apoe-/-) significantly attenuated atherosclerosis, with protection mediated by bone marrow-derived cells.
- Atheroprotection was associated with reduced foam cell formation and macrophage infiltration in plaques.
- Macrophage-specific LIPA deficiency impaired lipid uptake and downregulated CD36 expression, without affecting hepatic lipid metabolism or differentiation.
Conclusions:
- Macrophage Lysosomal acid lipase (LIPA) plays a critical role in promoting atherosclerosis by facilitating foam cell formation.
- Targeting macrophage LIPA may offer a novel therapeutic strategy for atherosclerosis treatment.
- LIPA deficiency impacts monocyte development and CD36 expression, key factors in macrophage lipid handling and plaque progression.
Abstract:
Lysosomal acid lipase (LIPA), one of the earliest and most impactful genetic factors linked to human coronary artery diseases, is highly expressed in macrophages despite predominant hepatic production. However, the functional importance of LIPA in macrophages remained largely unknown. Notably, individuals with atherosclerosis-risk alleles demonstrate elevated LIPA expression in monocytes and macrophages, but lower levels in liver and plasma, indicating a potential macrophage-specific regulatory role of LIPA on atherosclerosis. The development of atherosclerosis in genetic models lacking LIPA has presented challenges. To investigate whether macrophage LIPA influences atherosclerosis, we established Lipa-deficient mice on an Apoe-/- background. Lipa-/-Apoe-/- mice developed hepatosplenomegaly and enhanced myelopoiesis after being fed a high-fat diet, which aligns with observations in human Lipa deficiency. Unexpectedly, both Lipa+/-Apoe-/- and Lipa-/-Apoe-/- mice showed significantly attenuated atherosclerosis. This protection was recapitulated in Apoe-/- recipients reconstituted with bone marrow from either Lipa+/-Apoe-/- or Lipa-/-Apoe-/- donors. Mechanistically, such atheroprotection was linked to a notable reduction in foam cell formation and macrophage accumulation within plaques. Homozygous deficiency suppressed foam cells via impaired monocyte development and CD36 downregulation, whereas heterozygosity primarily decreased CD36 expression. In vitro, Lipa-/- macrophages exhibited diminished lipid uptake and CD36 expression, both reversed by Lipa re-expression. Notably, reduced Lipa expression in Lipa+/-Apoe-/- mice did not impact hepatic lipid metabolism or macrophage differentiation, as evidenced by flow cytometry and single-cell RNA sequencing. These findings highlight a novel role for Lipa in modulating macrophage behavior during atherosclerosis, suggesting that Lipa may serve as a promising therapeutic target for the treatment of atherosclerosis.
Related Concept Videos
Inflammation
Atherosclerosis I: Introduction
Differentiation of Common Myeloid Progenitor Cells
Formation of Lipopolysaccharides
Phosphoinositides and PIPs
Different phosphoinositides are synthesized and recruited on the cytosolic face of the plasma membrane. The localization of specific phosphoinositides concentrated in separate membrane...
IP3/DAG Signaling Pathway